Luteal estradiol pretreatment of poor and normal responders during GnRH antagonist protocol

References

• Fanchin R, Salomon L, Castelo-Branco A, et al. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod. 2003;18:2698–2703.
   PubMed Web of Science ®Google Scholar
• Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a cochrane review. Hum Reprod. 2002;17:874–885.
   PubMed Web of Science ®Google Scholar
• Klein NA, Battaglia DE, Fujimoto VY, et al. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab. 1996;81:1038–1045.
   PubMed Web of Science ®Google Scholar
• Devreker F, Pogonici E, De Maertelaer V, et al. Selection of good embryos for transfer depends on embryo cohort size: implication for the mila ovarian stimulation debate. Hum Reprod. 1999;14:3002–3008.
   PubMed Web of Science ®Google Scholar
• Chun SY, Eisenhauer KM, Minami S, et al. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology. 1996;137:1447–1456.
   PubMed Web of Science ®Google Scholar
• Tsai CC, Yen S. The effect of ethinyl-estradiol administration during early follicular phase on the gonadotrophin levels and ovarian function. J Clin Endocrinol Metab. 1971;33:917–923.
   PubMed Web of Science ®Google Scholar
• Le Nestour E, Marraoui J, Lahlou N, et al. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J Clin Endocrinol Metab. 1993;77:439–442.
   PubMed Web of Science ®Google Scholar
• de Ziegler D, Jaaskelainen AS, Brioschi PA, et al. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod. 1998;13:561–564.
   PubMed Web of Science ®Google Scholar
• Guivarc’h-Levêque A, Homer L, Arvis P, et al. Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes? Fertil Steril. 2011;96:872–876.
   PubMed Web of Science ®Google Scholar
• Keay S, Liversedge N, Mathur R, et al. Assisted conception following poor ovarian response to gonadotrophin stimulation. BJOG. 1997;104:521–527.
   Google Scholar
• Fanchin R, Cunha-Filho JS, Schonauer LM, et al. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril. 2003;79:316–321.
   PubMed Web of Science ®Google Scholar
• Hill MJ, McWilliams GD, Miller KA, et al. A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates. Fertil Steril. 2009;91:739–741.
   PubMed Web of Science ®Google Scholar
• Frattarelli JL, Hill MJ, McWilliams GD, et al. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril. 2008;89:1118–1122.
   PubMed Web of Science ®Google Scholar
• Sefrioui O, Madkour A, Aboulmaouahib S, et al. Women with extreme low AMH values could have in vitro fertilization success. Gynecol Endocrinol. 2019;35:170–173.
   PubMed Web of Science ®Google Scholar
• Cédrin-Durnerin I, Bständig B, Parneix I, et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod. 2007;22:109–116.
   PubMed Web of Science ®Google Scholar
• Franco JG, Jr, Baruffi LRL, Petersen CG, et al. Comparison of ovarian stimulation with recombinant FSH after 2nd phase protocols with GnRH analogs (I-Estradiol + Ganirelix versus IINafarelin. J Brasileiro Reprod Assist. 2003;7:27–33.
   Google Scholar
• Kolibianakis EM, Papanikolaou EG, Camus M, et al. Effect of oral contraceptive pill pre-treatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod. 2006;21:352–357.
   PubMed Web of Science ®Google Scholar
• Nyboe Andersen A, Witjes H, Gordon K, et al. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod. 2011;12:3413–3423.
   Google Scholar
• Smulders B, Van Oirschot SM, Farquhar C, et al. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2010;1:CD006109.
   Google Scholar
• Fanchin R, Castelo Branco A, Kadoch IJ, et al. Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation. Fertil Steril. 2004;81:1554–1559.
   PubMed Web of Science ®Google Scholar
• Dragisic KG, Davis OK, Fasouliotis SJ, et al. Use of a luteal estradiol patch and a gonadotropin releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertiliz aprotocol for controlled ovarian stimulation before in vitro fertilization in poor responders. Fertil Steril. 2005;84:1023–1026.
   PubMed Web of Science ®Google Scholar
• Cedrin-Durnerin I, Guivarc’h-Leveque A, Hugues JN. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial. Fertil Steril. 2012;97:1359–1364.
   PubMed Web of Science ®Google Scholar
• Elassar A, Mann JS, Engmann L, et al. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders. Fertil Steril. 2011;95:324–326.
   PubMed Web of Science ®Google Scholar
• Surrey E, Schoolcraft W. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73:667–676.
   PubMed Web of Science ®Google Scholar
• Frankfurter D, Dayal M, Dubey A, et al. Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder. Fertil Steril. 2007;88:1442–1445.
   PubMed Web of Science ®Google Scholar
• Blockeel C, Engels S, De Vos M, et al. Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reprod BioMed Online. 2012;24:272–280.
   PubMed Web of Science ®Google Scholar
• Chang EM, Han JE, Won HJ, et al. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization. J Assist Reprod Genet. 2012;29:225–230.
   PubMed Web of Science ®Google Scholar